Oral Testosterones Might Use REMS, CV Post-Market Study To Win Approval
US FDA advisory committee worries about off-label use of Lipocine's Tlando and Clarus' Jatenzo.
US FDA advisory committee worries about off-label use of Lipocine's Tlando and Clarus' Jatenzo.